EMA adopts guideline on using pharmacogenetics in evaluating pharmacokinetics of drugs
This article was originally published in SRA
Executive Summary
The European Medicines Agency has adopted a guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products1.